IMG_4644.JPG

Our Mission

Our calling is to impact the lives of people around the globe by harnessing the power and potential of the genome to help feed, fuel, and heal humanity

Image 2.png

Who we are

 

Sachi Bioworks is a Genetic Tools and Therapeutics company that develops nucleic acid molecules to target any gene in any organism. Our proprietary Facile Accelerated Specific Tool/Therapeutic (FAST) platform integrates innovations in systems biology, synthetic biology, chemistry, nanotechnology, and cell culture to develop high-precision tools/therapeutics that can probe and disrupt genes in diverse organisms in a facile and multiplexed manner. FAST platform uses design and build modules to generate hundreds to thousands of novel hybrid molecules called FASTmers in a matter of days. Our proprietary FASTmers offer improved specificity, transport, and low off-targeting. FAST enables precise, multiplexed, accelerated, cloning-free genetic tools to precisely manipulate gene regulation (switch ON and OFF).

Meet The Team

Anushree Chatterjee.JPG

Anushree Chatterjee, Ph.D.

co-founder, Chairperson, CEO

Dr. Anushree Chatterjee has 15+ years of experience in synthetic and systems biology.  She is the inventor of FAST technology. She received her Bachelors and Masters of Technology in Chemical Engineering from Indian Institute of Technology Delhi in 2006. She earned her Ph.D. in Chemical engineering at the University of Minnesota on understanding molecular mechanisms of antibiotic resistance transfer in clinical superbugs in 2011. She was a postdoctoral research fellow at the Theoretical Biology and Biophysics group at Los Alamos National Laboratory studying gene regulation of hepatitis C virus till 2012. In 2013, Anushree joined the faculty at University of Colorado Boulder. She has published 50+ papers in high-impact peer-reviewed journals, given 55 invited talks, and 70+ contributed talks. Anushree has received numerous awards including the DARPA Young Faculty Award, ACS Infectious Diseases Young Investigator Award, New Inventor of the Year award, Provost’s Faculty Achievement award, and the prestigious William M. keck Foundation grant award. Anushree’s research has been featured by academic and federal institutions such as the Material Research Society, Faculty of 1000, and the National Science Foundation, as well as popular national and international media outlets including BBC, CGTN America, and Voice of America. She has also founded/co-founded two Biotech startup companies, the non-profit organization Antimicrobial Regeneration Consortium Labs. She also an Associate Professor of Chemical and Biological Engineering at University of Colorado Boulder.

Prashant Nagpal -2.JPG

Prashant Nagpal, Ph.D.

co-founder, COO, CTO

Dr. Prashant Nagpal has more than 15 years of experience in nanoscience and nanotechnology, quantum biology, molecular spectroscopy, and physical chemistry.  He is the co-inventor of FAST technology. Prashant received his B.S. from Indian Institute of Technology Delhi in 2004, and earned his Ph.D. from University of Minnesota in 2009. After working for 2.5 years at Los Alamos National Laboratory as a post-doctoral scholar, he joined the University of Colorado Boulder in August 2012. His research has been published in more than 50 publication in peer reviewed, high-impact journals such as Science, Nature Materials, Nature Communications, Physical Review Letters, Nano Letters, JACS, ACS Nano, Angewandte Chemie, and he has filed and granted more than 20 patents based on his work, given over 50 invited talks, and has received numerous awards and honors including the New Inventor of the Year Award (2013), NSF CAREER Award (2014), Keck Foundation Research Award (2015), Outstanding Junior Faculty Award by University of Colorado (2017), and more recently, Emerging Leader in Biological Engineering (2019) award. His work has been highlighted in more than 100 national and international print and media outlets, and was recently featured in ABC Evening News, France 24, BBC, Newsweek, MSN, Times of India, R&D Magazine, Outlook, Indian Express, Huffington Post, Popular Mechanics, Daily Mail, The Statesman, and KGNU’s Science show “How on Earth”. He has also founded two Biotech startup companies, and the non-profit organization Antimicrobial Regeneration Consortium Labs.

Colleen Courtney-1.jpg

Colleen Courtney, Ph. D.

Director of Technology Development and Operations

Dr. Colleen Courtney has 8+ years of experience in biotechnology research including nanotechnology, engineered therapeutics, and host-pathogen interaction modulation. She received her B.S. in Chemical Engineering from the University of Maryland Baltimore County in 2012 and her PhD in Chemical Engineering from the University of Colorado Boulder in 2017. Her PhD work focused on engineered antimicrobials for multidrug-resistant superbugs including sequence-specific and nanotherapeutics. She held a postdoctoral position at Sandia National Laboratories in Livermore, CA in the Biotechnology and Bioengineering Department for three years and worked on numerous multi-disciplinary projects related to broad biodefense goals spanning from antimicrobials and antivirals to drug delivery of RNA therapies. While at Sandia, she additionally spent time in the Business Development Department focusing on intellectual property strategy and technical business development. 

Sadhana Sharma-1.jpg

Sadhana Sharma, Ph. D.

Director of Research and Development

Dr. Sadhana Sharma has 20+ years of experience in micro- and nano- technologies and biomaterials for developing nanomedicine, tissue engineered devices, and high throughput screening platforms for various biomedical applications.  She received her masters and Ph. D. in Bioseparations from the Indian Institute of Technology Delhi. She also received Ph.D. (Bioengineering) from the University of Illinois at Chicago (UIC) in 2002 where she developed nanostructured poly(ethylene glycol) thin films for microfabricated nanoporous controlled release chips for pharmaceutical delivery and immunoisolation applications.  She worked with various generations of controlled release platforms for cancer and cardiovascular applications and collaborated with startups further developing and commercializing this technology. She has also developed micro- / nanoparticulate or scaffold-based platforms for pharmaceutical, gene, and vaccine delivery for a variety of disease conditions. In addition, She has extensive experience in the development of photoclickable hydrogel-based 3-D high-throughput tissue mimetics for drug screening and disease modeling. She has authored over thirty-two research articles in peer-reviewed journals, nine book chapters / conference proceedings, presented over fifty-seven technical talks/posters, and has two patents issued to her name. Sadhana has received several awards throughout her career including Fellow of Ruth L. Kirschstein National Research Service Award. She also serves as a research faculty in Chemical and Biological Engineering at University of Colorado Boulder.

Colleen Courtney-1.jpg

Colleen Courtney, Ph. D.

Director of Technology Development and Operations

Dr. Colleen Courtney has 8+ years of experience in biotechnology research including nanotechnology, engineered therapeutics, and host-pathogen interaction modulation. She received her B.S. in Chemical Engineering from the University of Maryland Baltimore County in 2012 and her PhD in Chemical Engineering from the University of Colorado Boulder in 2017. Her PhD work focused on engineered antimicrobials for multidrug-resistant superbugs including sequence-specific and nanotherapeutics. She held a postdoctoral position at Sandia National Laboratories in Livermore, CA in the Biotechnology and Bioengineering Department for three years and worked on numerous multi-disciplinary projects related to broad biodefense goals spanning from antimicrobials and antivirals to drug delivery of RNA therapies. While at Sandia, she additionally spent time in the Business Development Department focusing on intellectual property strategy and technical business development. 

Sadhana Sharma-1.jpg

Sadhana Sharma, Ph. D.

Director of Research and Development

Dr. Sadhana Sharma has 20+ years of experience in micro- and nano- technologies and biomaterials for developing nanomedicine, tissue engineered devices, and high throughput screening platforms for various biomedical applications.  She received her masters and Ph. D. in Bioseparations from the Indian Institute of Technology Delhi. She also received Ph.D. (Bioengineering) from the University of Illinois at Chicago (UIC) in 2002 where she developed nanostructured poly(ethylene glycol) thin films for microfabricated nanoporous controlled release chips for pharmaceutical delivery and immunoisolation applications.  She worked with various generations of controlled release platforms for cancer and cardiovascular applications and collaborated with startups further developing and commercializing this technology. She has also developed micro- / nanoparticulate or scaffold-based platforms for pharmaceutical, gene, and vaccine delivery for a variety of disease conditions. In addition, She has extensive experience in the development of photoclickable hydrogel-based 3-D high-throughput tissue mimetics for drug screening and disease modeling. She has authored over thirty-two research articles in peer-reviewed journals, nine book chapters / conference proceedings, presented over fifty-seven technical talks/posters, and has two patents issued to her name. Sadhana has received several awards throughout her career including Fellow of Ruth L. Kirschstein National Research Service Award. She also serves as a research faculty in Chemical and Biological Engineering at University of Colorado Boulder.

Colleen Courtney-1.jpg

Colleen Courtney, Ph. D.

Director of Technology Development and Operations

Dr. Colleen Courtney has 8+ years of experience in biotechnology research including nanotechnology, engineered therapeutics, and host-pathogen interaction modulation. She received her B.S. in Chemical Engineering from the University of Maryland Baltimore County in 2012 and her PhD in Chemical Engineering from the University of Colorado Boulder in 2017. Her PhD work focused on engineered antimicrobials for multidrug-resistant superbugs including sequence-specific and nanotherapeutics. She held a postdoctoral position at Sandia National Laboratories in Livermore, CA in the Biotechnology and Bioengineering Department for three years and worked on numerous multi-disciplinary projects related to broad biodefense goals spanning from antimicrobials and antivirals to drug delivery of RNA therapies. While at Sandia, she additionally spent time in the Business Development Department focusing on intellectual property strategy and technical business development. 

Sadhana Sharma-1.jpg

Sadhana Sharma, Ph. D.

Director of Research and Development

Dr. Sadhana Sharma has 20+ years of experience in micro- and nano- technologies and biomaterials for developing nanomedicine, tissue engineered devices, and high throughput screening platforms for various biomedical applications.  She received her masters and Ph. D. in Bioseparations from the Indian Institute of Technology Delhi. She also received Ph.D. (Bioengineering) from the University of Illinois at Chicago (UIC) in 2002 where she developed nanostructured poly(ethylene glycol) thin films for microfabricated nanoporous controlled release chips for pharmaceutical delivery and immunoisolation applications.  She worked with various generations of controlled release platforms for cancer and cardiovascular applications and collaborated with startups further developing and commercializing this technology. She has also developed micro/ nanoparticulate or scaffold-based platforms for pharmaceutical, gene, and vaccine delivery for a variety of disease conditions. In addition, She has extensive experience in the development of photoclickable hydrogel-based 3-D high-throughput tissue mimetics for drug screening and disease modeling. She has authored over thirty-two research articles in peer-reviewed journals, nine book chapters / conference proceedings, presented over fifty-seven technical talks/posters, and has two patents issued to her name. Sadhana has received several awards throughout her career including Fellow of Ruth L. Kirschstein National Research Service Award. She also serves as a research faculty in Chemical and Biological Engineering at University of Colorado Boulder.

Jeff Wynalda, MBA

Manager of Strategy and Business Operations

Jeff Wynalda has 14 years of diverse work experience that allows him to effectively solve a wide range of business problems.  Armed with a B.S. in Mechanical Engineering from Purdue University, he spent 11 years at an Oil & Gas service company where he was involved in field engineering, operations management, and managed a recruiting division for North America.  In 2017, Jeff completed his M.B.A from the University of Texas at Austin and is now a senior finance manager at the world's largest winery. Jeff has been developing skills in FP&A, sales finance, operations, and helping solve business problems at the C-suite level. 

Our Advisors

Terry-Opgenorth.jpg

Terry Opgenorth, Ph. D.

  • Grey LinkedIn Icon
Dave Giarracco.jpg

David Giarracco

  • Grey LinkedIn Icon
Image 2.png
Sachi-Logo_landscape_FF_dark v2-01.png

Ph: 720-361-2159

info@sachibio.com

685 S Arthur Avenue, Unit 5,

Louisville, CO 80027

Subscribe to Our Newsletter

Thanks for submitting!

Follow Us On:

  • LinkedIn

© 2021 Sachi Bioworks Inc.